Conmed (NASDAQ: CNMD) reported Q2 EPS of $0.56, $0.03 better than the analyst estimate of $0.53. Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE